WESPAC Advisors’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-100,405
Closed -$1.99M 155
2023
Q3
$1.99M Sell
100,405
-321
-0.3% -$6.08K 1.49% 15
2023
Q2
$1.89M Sell
100,726
-3,664
-4% -$73.9K 1.51% 18
2023
Q1
$2.13M Buy
+104,390
New +$2.1M 2% 11

Other funds holding BTAL

WESPAC Advisors's BTAL Position: Q4 2023 in Review

WESPAC Advisors sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2023, closing a stake of 100,405 shares — an estimated $1.99M sold.

WESPAC Advisors first reported a position in BTAL in Q1 2023 and held it in 3 quarters. The position peaked at $2.13M in Q1 2023. 75 funds tracked by Wall St. Rank hold BTAL as of Q4 2023.

  • WESPAC Advisors reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2023 after selling out during the quarter.
  • WESPAC Advisors sold 100,405 AGF US Market Neutral Anti-Beta Fund shares in Q4 2023, an estimated $1.99M.
  • WESPAC Advisors first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2023 and held it in 3 quarters.
  • WESPAC Advisors's AGF US Market Neutral Anti-Beta Fund position peaked at $2.13M in Q1 2023.
  • 75 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2023.

Based on WESPAC Advisors's 13F filing for Q4 2023, filed 26 Jan 2024.